Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Pharmacokinetics of Ticagrelor in Infants and Toddlers Aged <24 Months with Sickle Cell Disease

Baba PD Inusa, MD, Adlette Inati, MD, Philip Maes, MD, Jessie Githanga, MBChB, MMed, Miguel R. Abboud, MD, Maurizio Miano, Elena Cela, Videlis Nduba, Mohammad Niazi, Magnus Åstrand, Kevin Persson, Anders Rikard Berggren, MD PhD, Glenn Carlson, MD

Blood (2019) 134 (Supplement_1): 1005.

https://doi.org/10.1182/blood-2019-129855

Published: 2019

Journal Articles

Comparison of New Oral Anticoagulants (NOAC) Based Double Therapy Versus Vitamin K Antagonist Based Triple Therapy in Patients Undergoing Percutaneous Coronary Intervention with Atrial Fibrillation: A Systematic Review and Meta-Analysis

Muhammad Zain Farooq, MD MBBS, Prasanth Lingamaneni, Muhammad Saad Farooq, MBBS, Aakash Putta, MD MBBS, Sheeba Ba Aqeel, VV Pavan Kedar Mukthinuthalapati, Ankit Mangla, MBBS, MD, Paul Rubinstein, MD

Blood (2019) 134 (Supplement_1): 4963.

https://doi.org/10.1182/blood-2019-129607

Published: 2019

Journal Articles

TNF-Induced Vaso-Occlusive and Inflammatory Processes in Mice with Sickle Cell Anemia Are Abrogated By the Platelet Activation Inhibitor, Prasugrel

Hanan Chweih, M.Sc., Juliete A.F. Silva, PhD, Erica M.F. Gotardo, PhD, Pamela L. Brito, B.Sc, Guilherme G.O. Barbosa, PhD, Flavia Garcia, PhD, Wilson A. Ferreira, Jr., PhD, Flavia C. Leonardo, PhD, Carla F. Franco-Penteado, PhD, Fernando F. Costa, MD, PhD, Nicola Conran, PhD

Blood (2018) 132 (Supplement 1): 2354.

https://doi.org/10.1182/blood-2018-99-118633

Published: 2018

Journal Articles

Pharmacokinetics, Pharmacodynamics and Safety of Ticagrelor in Children with Sickle Cell Disease: Results of a Two-Part Phase 2 Study

Lewis L Hsu, MD PhD, S Sarnaik, S Williams, C Amilon, M Rensfeldt, A Berggren

Blood (2017) 130 (Supplement 1): 2251.

https://doi.org/10.1182/blood.V130.Suppl_1.2251.2251

Published: 2017

Journal Articles

Candidate Gene Associations with Vaso-Occlusive Crisis in Children with Sickle Cell Anemia Enrolled in the Multinational DOVE Trial

Carolyn C Hoppe, MD, Joseph A Jakubowski, PhD, Wendra M Foster, Lori E Heath, Sreekumar Pillai, Bhatnagar Pallav

Blood (2017) 130 (Supplement 1): 962.

https://doi.org/10.1182/blood.V130.Suppl_1.962.962

Published: 2017

Journal Articles

Efficacy and Safety of Prothrombin Complex Concentrate in Patients Undergoing Major Cardiac Surgery

Deepa Jayakody Arachchillage, Simona Deplano, Eleanor Dunnett, Steve Owen, Louise Tillyer, Michael Laffan

Blood (2016) 128 (22): 3852.

https://doi.org/10.1182/blood.V128.22.3852.3852

Published: 2016

Journal Articles

Geographic Differences in Phenotype and Treatment of Children with Sickle Cell Anemia from the Multinational DOVE Study

Baba Inusa, Raffaella Colombatti, MD PhD, David C Rees, MA, FRCP, Matthew M Heeney, MD, Carolyn C Hoppe, MD, Bernhards Ogutu, MD PhD, Hoda M Hassab, MD, Chunmei Zhou, MS, Suqin Yao, PhD, Patricia B Brown, BSN, RN, Lori E Heath, MS, Joseph A. Jakubowski, PhD, Miguel R Abboud, MD

Blood (2016) 128 (22): 3653.

https://doi.org/10.1182/blood.V128.22.3653.3653

Published: 2016

Journal Articles

Regional- and Age-Related Differences in Pain in Children with Sickle Cell Anemia: Results from the Multinational DOVE Study

Julie Kanter, MD, Lori E Heath, MS, Chunmei Zhou, MS, Tsiri Agbenyega, MBChB, PhD, Raffaella Colombatti, MD PhD, Carlton Dampier, MD CPI, Hoda M Hassab, MD, Deepa Manwani, MD, Nancy Robitaille, MD, Patricia B Brown, BSN, RN, Joseph A. Jakubowski, PhD, Suqin Yao, PhD, Jack Knorr, PhD, Carolyn C Hoppe, MD

Blood (2016) 128 (22): 3654.

https://doi.org/10.1182/blood.V128.22.3654.3654

Published: 2016

Journal Articles

Clopidogrel Treatment Is Associated with a Decrease in Cancer Incidence

Avi Leader, MD, Ravit Zelikson-Saporta, Uri Rozovski, MD, David Pereg, MD, Pia Raanani, MD, Galia Spectre, MDPhD, Michael Lishner, MD, Doron Hermoni, MD

Blood (2015) 126 (23): 1124.

https://doi.org/10.1182/blood.V126.23.1124.1124

Published: 2015

Journal Articles

Possible Role Of Circulating Adenine Nucleotides and Platelet Activation In The Pathogenesis Of Sickle Cell Disease: Observations In a Murine Model

Kousaku Ohno, PhD, Hisako Tanaka, Naozumi Samata, Tomizawa Atsuyuki, PhD, Makoto Mizuno, Joseph A. Jakubowski, PhD, Atsuhiro Sugidachi, PhD

Blood (2013) 122 (21): 2212.

https://doi.org/10.1182/blood.V122.21.2212.2212

Published: 2013

Journal Articles

Clopidogrel Modulates LPS-Induced Systemic Inflammation Through a P2Y 12 receptor Independent Pathway

Elisabetta Liverani, PhD, Mario C Rico, MD, Alexander Tsygankov, PhD, Laurie E Kilpatrick, PhD, Satya P. Kunapuli, PhD

Blood (2013) 122 (21): 2309.

https://doi.org/10.1182/blood.V122.21.2309.2309

Published: 2013

Journal Articles

Differential Expression Of Platelet Proteins In Stable Unstable Coronary Artery Disease and Acute Coronary Syndromes

James P McRedmond, PhD, Brid Holohan, BSc, Andrew K Roy, MB, Rosanna Inzitari, PhD, Kawthar Saad Alghamdi, BSc, Martin Quinn, PhD, Desmond J Fitzgerald, MD

Blood (2013) 122 (21): 3622.

https://doi.org/10.1182/blood.V122.21.3622.3622

Published: 2013

Journal Articles

Prasugrel in Children with Sickle Cell Disease: Pharmacokinetic and Pharmacodynamic Characteristics from an Open-Label, Adaptive-Design, Dose-Ranging Study

Lori Styles, MD, Joseph A. Jakubowski, PhD, Darell E. Heiselman, MD, Lori E. Heath, MS, Chunmei Zhou, MS, Charles T. Quinn, MD, MS, Matthew M. Heeney, MD, Rupa Redding-Lallinger, MD, David S. Small, PhD, Brian A. Moser, MS, Kenneth J. Winters, MD

Blood (2012) 120 (21): 3213.

https://doi.org/10.1182/blood.V120.21.3213.3213

Published: 2012

Journal Articles

Platelet Activation and Inhibition in Sickle Cell Disease (PAINS) Study

Andrew L. Frelinger, III, PhD, Joseph A. Jakubowski, PhD, Julie K. Brooks, MS, Sabrina L. Zayas, BS, Michelle A. Berny-Lang, PhD, Marc R. Barnard, MS, Matthew M. Heeney, MD, Alan D. Michelson, MD

Blood (2012) 120 (21): 5147.

https://doi.org/10.1182/blood.V120.21.5147.5147

Published: 2012

Journal Articles

Translating Research Into Policy: A Review of Pharmacovigilance Efforts From the Southern Network On Adverse Reactions (SONAR) Group

Charles Bennett, MD, PhD, MPP, Leann Norris, PharmD, Zaina Parvez Qureshi, PhD, MPH, April Miller, PharmD, Brandon Bookstaver, PharmD, BCPS (AQ-ID), AAHIVE, Donald Mattison, M.D., CAPT, USPHS

Blood (2011) 118 (21): 4756.

https://doi.org/10.1182/blood.V118.21.4756.4756

Published: 2011

Journal Articles

Biomarkers of Hemostatic Activation in a Randomized, Double-Blind, Phase 2 Study of Prasugrel Compared to Placebo in Adults with Sickle Cell Disease

Ted Wun, Charles L. Knupp, MD, Lillian E. McMahon, MD, John J. Strouse, MD, PhD, Chunmei Zhou, MS, Lori E. Heath, MS, Chuke E. Nwachuku, MA, MPH, DrPH, Joseph A. Jakubowski, PhD, Kenneth J. Winters, MD, Jeffrey S. Riesmeyer, MD

Blood (2011) 118 (21): 2127.

https://doi.org/10.1182/blood.V118.21.2127.2127

Published: 2011

Journal Articles

A Randomized, Double-Blind, Adaptive Phase 2 Multi-Center Study of Prasugrel Compared to Placebo in Adults with Sickle Cell Disease

Ted Wun, Denis Soulieres, MD, FRCPC, MSc, Lakshmanan Krishnamurti, MD, Abdullah Kutlar, MD, Kenneth Ataga, MD, Chunmei Zhou, MS, Lori E. Heath, MS, Chuke E. Nwachuku, MA, MPH, DrPH, Joseph A. Jakubowski, PhD, Kenneth J. Winters, MD, Jeffrey S. Riesmeyer, MD

Blood (2011) 118 (21): 847.

https://doi.org/10.1182/blood.V118.21.847.847

Published: 2011

Journal Articles

Prasugrel Aggravates the Inflammatory Response in a PG-PS-Induce Arthritis Model,

Analia E Garcia, DMD, Mario C Rico, MD, Elisabetta Liverani, PhD, Satya P. Kunapuli, PhD, Raul A. De La Cadena, MD

Blood (2011) 118 (21): 3268.

https://doi.org/10.1182/blood.V118.21.3268.3268

Published: 2011

Journal Articles

P2Y12 Is Involved in Cancer Metastasis,

Yanhua Wang, Yueping Sun, Ph.D, Ding Li, Ph.D, Lin Zhang, Master's, degree, Kemin Wang, Weiran Chai, Ph.D, Xinping Luo, T. Kent Gartner, PhD, Junling Liu

Blood (2011) 118 (21): 3356.

https://doi.org/10.1182/blood.V118.21.3356.3356

Published: 2011

Journal Articles

Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty Year Review

Zaina Parvez Qureshi, PhD, MPH, John Armstrong, PhD, Charles Bennett, MD, PhD, MPP

Blood (2011) 118 (21): 2226.

https://doi.org/10.1182/blood.V118.21.2226.2226

Published: 2011

NARROW

Pharmacokinetics of Ticagrelor in Infants and Toddlers Aged <24 Months with Sickle Cell Disease

Comparison of New Oral Anticoagulants (NOAC) Based Double Therapy Versus Vitamin K Antagonist Based Triple Therapy in Patients Undergoing Percutaneous Coronary Intervention with Atrial Fibrillation: A Systematic Review and Meta-Analysis

TNF-Induced Vaso-Occlusive and Inflammatory Processes in Mice with Sickle Cell Anemia Are Abrogated By the Platelet Activation Inhibitor, Prasugrel

Pharmacokinetics, Pharmacodynamics and Safety of Ticagrelor in Children with Sickle Cell Disease: Results of a Two-Part Phase 2 Study

Candidate Gene Associations with Vaso-Occlusive Crisis in Children with Sickle Cell Anemia Enrolled in the Multinational DOVE Trial

Efficacy and Safety of Prothrombin Complex Concentrate in Patients Undergoing Major Cardiac Surgery

Geographic Differences in Phenotype and Treatment of Children with Sickle Cell Anemia from the Multinational DOVE Study

Regional- and Age-Related Differences in Pain in Children with Sickle Cell Anemia: Results from the Multinational DOVE Study

Clopidogrel Treatment Is Associated with a Decrease in Cancer Incidence

Possible Role Of Circulating Adenine Nucleotides and Platelet Activation In The Pathogenesis Of Sickle Cell Disease: Observations In a Murine Model

Clopidogrel Modulates LPS-Induced Systemic Inflammation Through a P2Y 12 receptor Independent Pathway

Differential Expression Of Platelet Proteins In Stable Unstable Coronary Artery Disease and Acute Coronary Syndromes

Prasugrel in Children with Sickle Cell Disease: Pharmacokinetic and Pharmacodynamic Characteristics from an Open-Label, Adaptive-Design, Dose-Ranging Study

Platelet Activation and Inhibition in Sickle Cell Disease (PAINS) Study

Translating Research Into Policy: A Review of Pharmacovigilance Efforts From the Southern Network On Adverse Reactions (SONAR) Group

Biomarkers of Hemostatic Activation in a Randomized, Double-Blind, Phase 2 Study of Prasugrel Compared to Placebo in Adults with Sickle Cell Disease

A Randomized, Double-Blind, Adaptive Phase 2 Multi-Center Study of Prasugrel Compared to Placebo in Adults with Sickle Cell Disease

Prasugrel Aggravates the Inflammatory Response in a PG-PS-Induce Arthritis Model,

P2Y12 Is Involved in Cancer Metastasis,

Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty Year Review

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only